|
Analysis of King PharmaceuticalsPublished by: Aruvian Research Published: May. 1, 2008 - 70 Pages Table of Contents
AbstractKing Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products. The company’s wholly owned subsidiaries are Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., Meridian Medical Technologies, Inc., Parkedale Pharmaceuticals, Inc., King Pharmaceuticals Canada Inc. and Monarch Pharmaceuticals Ireland Limited. The company markets its branded prescription pharmaceutical products to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons and hospitals across the United States and in Puerto Rico. Aruvian Research presents Analysis of King Pharmaceuticals. A complete and comprehensive analysis of King Pharmaceuticals, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself. Company analysis from Aruvian includes a history of King Pharmaceuticals, a business segment analysis of the segments King Pharmaceuticals operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors. A financial analysis of King Pharmaceuticals is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more. A SWOT Framework Analysis of King Pharmaceuticals completes this in-depth company analysis. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||